Thought Leadership | Fish & Richardson

Diversity, Equity & Inclusion

Pro Bono & Social Responsibility

Legal Operations

Legal Project Management

Knowledge Management

Legal Technology Services

Patent Litigation

Trademark, Copyright & Media Litigation

Trade Secret Litigation

Chancery & Corporate Governance

<p><em>Inter Partes </em>Review</p>

Post-Grant Review

<p><em>Ex Parte</em> Reexamination</p>

Supplemental Examination

Patent Prosecution

Strategic Patent Counseling & Opinions

Patent Portfolio Management

Unitary Patent & Unified Patent Court

IP Licensing, Transactions & Agreements

Trademark & Copyright Counseling & Prosecution

Strategic Counseling, Registration & Opinions

Advertising & Marketing

Domain Names & Internet

TTAB Oppositions & Cancellations

Digital Millennium Copyright Act

Transactions & Agreements

Regulatory & Government Affairs

Communications & Spectrum Regulation

Drug & Medical Device Regulation

mHealth & Telemedicine

Privacy & Data Security

Electrical & Computer Technology

Software & Internet

Consumer Electronics

Artificial Intelligence

Digital Media & E-Commerce

Financial, Business & FinTech Services

Telecommunications

Energy & Chemicals

Biotech & Diagnostics

Medical Devices

Pharmaceuticals

Academic Research & Medical Centers

Transportation, Aerospace & Defense

Autonomous Vehicles

Thought Leadership

IP Law Essentials

Post-Grant Annual Reports

Search results

Blog | March 24, 2016

Federal Circuit Tells Affected Parties Not to Fear Its Ever-Expanding Refusal to Review Post-Grant Institution Decisions

Blog | February 26, 2016

Judge Lord Grants Motion to Quash Subpoena Issued at Close of Fact Discovery

Blog | February 09, 2016

One Step Closer to a Federal Private Cause of Action for Trade Secret Misappropriation: The Defend Trade Secrets Act

Article | February 02, 2016

What The Court Got Wrong About Hatch-Waxman In Alcon

Blog | January 29, 2016

The Federal Circuit trend to strengthen the standard for definiteness

Article | January 22, 2016

Patent Owners Should Not Fear the Unified Patent Court

Blog | January 20, 2016

An Increased Emphasis on "Proportional Discovery"

Article | December 08, 2015

Changes to PTAB's Interpretation Standard Have Many Uncertain on Post-Grant Filings

Article | December 07, 2015

Will the Trans-Pacific Partnership Derail Biologics?

Blog | December 04, 2015

EU Trademark Changes in 2016

Article | December 02, 2015

Patent Infringement at the ITC: Implications for Brand-Name Drug Companies

Article | November 18, 2015

Fed. Cir. Limits Safe Harbor for Post-Approval Conduct